Chronic Hepatitis News

The use of amoxicillin-clavulanate with prednisolone did not improve 2-month survival compared with prednisolone alone in patients hospitalized with severe alcohol-related hepatitis, according to data in JAMA.

In a Healio video exclusive, Jeff Baxter, president and CEO of VBI Vaccines, discusses the current burden of hepatitis B virus infection and shares updates on prevention and treatment strategies for Hepatitis Awareness Month.

May is Hepatitis Awareness Month, an annual campaign to raise awareness for viral hepatitis and its impact in the U.S. — and a month-long opening to address the importance of vaccination and testing for viral hepatitis with your patients.

Larsucosteral was well-tolerated and improved short-term biomarkers of liver injury or disease in a subset of patients with moderate to severe alcohol-associated hepatitis, according to research in The American Journal of Gastroenterology.

Metabolic comorbidities heightened risk for adverse liver-related events among patients with chronic hepatitis B virus, with the highest risk found among patients with multiple comorbidities, according to research.

Although Black individuals with chronic hepatitis B were less likely to meet treatment criteria, researchers reported no significant differences in treatment initiation between racial groups, according to data in JAMA Network Open.

Hepatitis C virus among the U.S. obstetric population rose nearly 10-fold over 20 years, which might reflect an increase in screening or prevalence, according to researchers.

A call back system in Taiwan helped retrieve patients with chronic hepatitis C virus infection who were lost to follow-up and has the potential to boost micro-elimination efforts, according to research in BMC Gastroenterology.

SEATTLE — The ALLIANCE trial showed positive data on bictegravir/emtricitabine/tenofovir alafenamide treatment for HIV and hepatitis B coinfection while also providing data on treatment outcome predictors.

WASHINGTON — Active IV or prescription drug use did not affect attainment of sustained virologic response when treatment adherence for hepatitis C virus was already variable, according to a poster presented at The Liver Meeting.